THE NEW STANDARD FOR EXOSOMES IN AESTHETICS
Cartessa presents Chronos, the latest innovation in regenerative aesthetics that harnesses the power of exosomes. Crafted in highly specialized laboratories, this advanced line of biologics is defined by its traceability, purity, and potency. Chronos sets a new benchmark in aesthetic treatments, available exclusively through Cartessa Aesthetics.
TRACEABLE, PURE, POTENT EXOSOMES
Exosomes are naturally occurring, microscopic vesicles that play a crucial role in cell communication, carrying proteins, lipids, and RNA between cells. In aesthetics, they are trending due to their ability to enhance treatment efficacy and accelerate recovery, offering a new frontier in personalized and effective skincare solutions.
Produced in an FDA-compliant, ISO 7, cGMP-certified lab, Chronos products embody the highest standards in exosome technology and treatments, combining reliability and cutting-edge science.
A Milestone in Exosome Technology
ExoCR, the first exosome product in the Chronos line, embodies the latest advancements in biological science. Here's what sets ExoCR apart:
- Advanced Distillation: ExoCR is a single-source, non-lyophilized biologic, uniquely designed to target dermal fibroblasts with precision.
- High Particulate Count: Contains more than 50 billion particulates, ensuring a rich concentration for effective results.
- Intact Exosomes: Features more than 10 billion intact exosomes, harnessing their potential to revolutionize aesthetic treatments.
- Verified Composition: ExoCR has been validated to contain over 1,000 growth factors and cytokines, tapping into the fundamental processes of biological regeneration.
- Wharton’s Jelly Derived: The formulation is derived from Wharton’s Jelly, a perinatal tissue source abundant in exosomes, regenerative properties, and essential growth factors.
Position your practice at the forefront of aesthetic innovation and offer your patients this cutting-edge biologic.
TREATMENTS THAT DELIVER RESULTS
When used in combination with other leading aesthetic treatments—such as microneedling and laser resurfacing—ExoCR delivers noticeable results for your patients.
Individual results and treatments needed may vary.
DISCLAIMER: Cartessa Aesthetics does not offer Mesenchymal Stem Cell Exosomes or Wharton’s Jelly as a cure for any condition, disease, or injury. No statements or implied treatments on this website have been evaluated or approved by the FDA. This website contains no medical advice.
FEATURED WEBINARS
EXOSOMES IN AESTHETICS & NEW CHRONOS EXO CR
We sit down with the lead scientist behind Chronos ExoCR to better understand the science behind exosomes and how providers can evaluate products.
My Practice Before & After Exosomes
Featuring: Jeffrey Antimarino, MD, FACS & Angie Johnston, Nurse Practitioner, MSN, FNP
The team at Bellissimo Plastic Surgery & Medispa share how ExoCR helps enhance patient experience, clinical outcomes, and ROI.
NEWS & INSIGHTS
How Our Practice Found Success in Exosomes with Chronos EXO CR
Dr. Marc Estes and Dr. Rickin Shah, founders of PURE Regenerative Medicine, share their approach to exosomes in aesthetics and experience with EXO CR.
Continue ReadingElevating the Post-Treatment Experience
Post-treatment care is an essential part of the aesthetic experience and can help improve both recovery and outcomes.
Continue ReadingBioRestorative Therapies Announces Exclusive Commercial Agreement with Cartessa
BioRestorative Therapies has announced a transformative commercial agreement with Cartessa to partner on cell-based biologics for the Chronos lines.
Continue Reading